Laurenz Kellenberger is Chief Scientific Officer for Basilea Pharmaceutica AG and Chairman at Basilea Pharmaceutica China Ltd. (a subsidiary of Basilea Pharmaceutica AG).

He is also Director-Medicinal Chemistry & Chemical Biology at Swiss Chemical Society.

He received a doctorate from Swiss Federal Institute of Technology and a doctorate from the University of Cambridge.